3.0.0 1497 2025-12-05T08:43:10Z 2025-12-05T08:43:10Z Senate S S 2023-05-09 118 https://www.congress.gov/bill/118th-congress/senate-bill/1497 ssfi00 Finance Committee Senate Standing Referred To 2023-05-09T21:17:29Z 118 3134 HR 2024-12-17 Referred to the Subcommittee on Health. Identical bill CRS 2023-05-09 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2023-05-09 Introduced in Senate IntroReferral 10000 9 Library of Congress S001203 Sen. Smith, Tina [D-MN] Tina Smith D MN N Health Accounting and auditing 2023-07-07T19:30:31Z Business ethics 2023-07-07T19:30:31Z Business records 2023-07-07T19:30:31Z Competition and antitrust 2023-07-07T19:30:31Z Congressional oversight 2023-07-07T19:30:31Z Digestive and metabolic diseases 2023-07-07T19:30:31Z Government information and archives 2023-07-07T19:30:31Z Health care costs and insurance 2023-07-07T19:30:31Z Health care coverage and access 2023-07-07T19:30:31Z Health information and medical records 2023-07-07T19:30:31Z Health programs administration and funding 2023-07-07T19:30:31Z Health technology, devices, supplies 2023-07-07T19:30:31Z Indian social and development programs 2023-07-07T19:30:31Z Inflation and prices 2023-07-07T19:30:31Z Intergovernmental relations 2023-07-07T19:30:31Z Licensing and registrations 2023-07-07T19:30:31Z Manufacturing 2023-07-07T19:30:31Z Minority health 2023-07-07T19:30:31Z Performance measurement 2023-07-07T19:30:31Z Prescription drugs 2023-07-07T19:30:31Z Public contracts and procurement 2023-07-07T19:30:31Z Public-private cooperation 2023-07-07T19:30:31Z Retail and wholesale trades 2023-07-07T19:30:31Z Sales and excise taxes 2023-07-07T19:30:31Z State and local finance 2023-07-07T19:30:31Z State and local government operations 2023-07-07T19:30:31Z Health 2023-05-22T17:00:30Z

00 2023-05-09 Introduced in Senate 2024-01-18T19:10:28Z <p><b>Emergency Access to Insulin Act of 2023</b></p> <p>This bill reduces the marketing exclusivity period for biological drug products from 12 to 7 years and establishes policies and programs designed to increase access to prescription insulin.</p> <p>Specifically, the bill requires the Department of Health and Human Services (HHS) to award grants to states to create insulin card programs, which provide uninsured or underinsured individuals with insulin at no cost for specified time periods. Payments for insulin prescriptions made through the program must count toward an underinsured individual&rsquo;s health plan deductible or other out-of-pocket expenses required under the plan. Further, HHS must collect annual fees from insulin manufacturers, based on each manufacturer&rsquo;s market share, equal to the total estimated expenditures under the insulin grants program.</p> <p>Subject to certain exceptions, the bill also establishes an excise tax on insulin manufacturers when the price of an insulin product spikes. The tax amount is a specified percentage of the revenue a manufacturer received as a result of the price spike. The tax amount increases in tiers based on the percentage of the price spike for that product.</p>

Display Title 45 2024-07-24T15:22:18Z Short Title(s) as Introduced 101 2024-05-24T13:40:13Z Introduced in Senate IS Official Title as Introduced 6 2023-05-19T02:58:58Z Introduced in Senate IS Introduced in Senate 2023-05-09T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s1497is/xml/BILLS-118s1497is.xml 2023-05-09 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.